Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 17.04.2024
EV Digital Invest AG
EV Digital Invest AG fulfils forecast for financial year 2023
Transformation into a diversified investment platform is proceeding smoothly – with a new brand, the acquisition of a digital asset management company, new products, ECSP licensing by BaFin and successful internationalisation, the company is well positioned to generate growth in the [ … ]
Wed, 17.04.2024
EV Digital Invest AG
EV Digital Invest AG fulfils forecast for financial year 2023
Transformation into a diversified investment platform is proceeding smoothly – with a new brand, the acquisition of a digital asset management company, new products, ECSP licensing by BaFin and successful internationalisation, the company is well positioned to generate growth in the [ … ]
Wed, 17.04.2024
SINGULUS TECHNOLOGIES AG
Press Release
SINGULUS TECHNOLOGIES develops TIMARIS STM Coating System for the Production of Micro-LEDs
Kahl am Main, April 17, 2024 - SINGULUS TECHNOLOGIES has introduced a modular high-vacuum sputtering system of the type TIMARIS STM. The system offers significant progress in a specialized segment of semiconductor production: the manufacture [ … ]
Wed, 17.04.2024
Veganz Group AG
Disclosure of inside information pursuant to Article 17 (1) of the Regulation (EU) 596/2014 on market abuse (market abuse regulation)
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION, DISSEMINATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH [ … ]
Wed, 17.04.2024
Defence Therapeutics Inc.
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
Vancouver, BC, Canada, April 17th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce that FMS Consult GmbH (“F [ … ]
Wed, 17.04.2024
Legal Finance SE
The Frankfurt-based litigation financier Legal Finance SE, a subsidiary of the stock-market listed company Nakiki SE (ISIN DE000WNDL300), is taking massive action against online casinos: According to current German legislation, most online casinos are illegal until 2021 and must compensate players for all losses incurred in recent years. This means [ … ]
Wed, 17.04.2024
Evotec SE
Hamburg, Germany, 17 April 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer (“CPO”), effective 15 June 2024. Aurélie will be joining Evotec’s Management Board, bringing with her a wealth of experience and experti [ … ]
Wed, 17.04.2024
Spexis AG
Ad hoc announcement pursuant to Art. 53 LR
Allschwil, Switzerland, April 17, 2024
Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
The Western District Court of the Canton Basel-Landschaft has granted Spexis [ … ]
Wed, 17.04.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Publication of audited Consolidated & Statutory FY2023 Financial Statements of Kinarus Therapeutics Holding AG
Announcement of the postponement of the publication of the Annual Report 2023
Announcement of details and timeline of the contemplated Reverse Share Split
Announcement of final timeline for [ … ]
Wed, 17.04.2024
R&S Group Holding AG
Ad hoc announcement pursuant to Art. 53 LR
R&S Group publishes annual report 2023 with strong sales and record profitability and confirms good start into 2024 with high cash conversion
Sissach/BL, Switzerland, 17 April 2024 – R&S Group Holding AG (SIX: RSGN) today published its inaugural annual report as a publicly listed company, wherein [ … ]